Intellia Therapeutics Inc
F:38I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intellia Therapeutics Inc
F:38I
|
US |
|
G
|
Gap Inc
BMV:GPS
|
US |
|
Heineken Holding NV
F:4H50
|
NL |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
A
|
Alaska Air Group Inc
XBER:ALK
|
US |
|
C
|
Capital One Financial Corp
F:CFX
|
US |
|
Q
|
Quinstreet Inc
XBER:5Q8
|
US |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
Sanofi SA
PAR:SAN
|
FR |
|
Lu-Ve SpA
MIL:LUVE
|
IT |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
Linde PLC
NASDAQ:LIN
|
UK |
|
Super Group Ltd
F:S8G1
|
ZA |
|
MongoDB Inc
NASDAQ:MDB
|
US |
|
Concentrix Corp
F:CO8
|
US |
|
K
|
KCE Electronics PCL
SET:KCE
|
TH |
|
Suncor Energy Inc
TSX:SU
|
CA |
|
D
|
DSV A/S
XMUN:DS81
|
DK |
|
B
|
Banco de Sabadell SA
DUS:BDSB
|
ES |
|
B
|
BAE Systems PLC
XBER:BSP
|
UK |
|
I
|
Illumina Inc
DUS:ILU
|
US |
|
PTC Inc
LSE:0ACE
|
US |
|
R
|
Rio Tinto PLC
OTC:RTPPF
|
UK |
Bankruptcy Probability
Intellia Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Intellia Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Intellia Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Intellia Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
